PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 74: Articles 36501-37000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. A survey of users and nonusers of contraceptives in Antigua.
  2. Survey on the extent of knowledge and practice of family planning methods in a sub sample of SRS units.
  3. Survey on the sale of contraceptives. Study 32.
  4. A survey to evaluate the effectiveness of family planning programs. [Una encuesta para evaluar la eficacia de los programas de planificacion familiar.]
  5. Swedish assistance in the field of population and family planning.
  6. Synthesis of the contraceptive progestin lynestrenol-tritiated from tritiated estr-4-en-17-one.
  7. Systemic contraception.
  8. Systemic effects and complications of the oral contraceptives. (Paper and workbook, 1st version)
  9. Systemic LH changes during steroidal contraception.
  10. Systems analysis in family planning programming.
  11. A systems description of the family planning program in Taiwan.
  12. Taiwan (Family planning communication program)
  13. Taiwan tests an innovation in family planning.
  14. Taiwan: appraising the effect of a family planning program through an areal analysis.
  15. Talking politics: family planning in the National Health Service.
  16. Teaching family planning in Eastern Europe: the significance of the high abortion rate.
  17. Teaching family planning in Latin America, 1973: a five-year survey-report.
  18. Teaching family planning in the Latin American medical schools.
  19. Teaching family planning in the Pakistan medical schools and its relationship to the Pakistan National Programs.
  20. Teaching family planning to medical students and physicians.
  21. Teaching family planning to medical students and practitioners in India.
  22. The teaching of family planning in medical and nursing schools.
  23. Teaching of family planning in medical college in Bangladesh.
  24. The teaching of population/family planning in medical schools.
  25. Teamwork in family planning.
  26. Technical supervision of family planning program in Bangladesh.
  27. Technical supervision of family planning program: logistics, problems, and prospects.
  28. The teenage birth control dilemma and public opinion.
  29. Tennessee: using a statewide data system for family planning.
  30. Tentative overview of the medical and clinical activities performed by the family planning associations of the western hemisphere region January 1-December 31, 1972.
  31. Testing of contraceptives for aftereffects on fertility in rats: the choice of doses. (Abstract only)
  32. Thailand: fertility and family planning among rural and urban women.
  33. Theoretical and methodological considerations in the prediction of family planning intentions and behavior.
  34. Theoretical and methodological critique of surveys of knowledge attitude s and practice of family planning in Africa.
  35. Thromboelastographic studies in oral contraception.
  36. Thromboembolic risks in oral contraception.
  37. Thromboembolism and oral contraceptives.
  38. Thromboembolism and oral contraceptives. (Letter to the editor)
  39. Thrombosis and oral contraceptives: possible predisposition.
  40. Thrombotic predisposition associated with oral contraceptives.
  41. Tietze's method for the collection of data for use-effectiveness of contraception studies.
  42. Tolerance of the normocyclic sequential preparation Oraconal and of various hormonally neutral and gestagen-potent contraceptives in medical practice: Result of a group study by 173 gynecologists of 1539 women. [Zur Vertraglichkeit des normozyklischen Sequenzpraparates Oraconal, und einiger hormonneutraler sowie gestagenbetonter Kontrazeptiva in der Arztlichen Praxis: Ergebnis einer Gemeinschaftsstudie von 173 niedergelassenen Gynakologen an 1539 Frauen.]
  43. Total and free plasma-tryptophan concentration and oral contraception.
  44. Urinary 4-pyridoxic acid and plasma pyridoxal phosphate levels in oral contraceptive users eating diets of defined Vitamin B6 content. (Abstract only)
  45. Urinary excretion or quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration.
  46. Uruguay. (Family planning)
  47. Use of a long-acting injectable contraceptive in a postpartum family planning program.
  48. Use of a prolonged-action contraceptive applied every 6 months. Preliminary report. [Empleo de un anticonceptivo de accion prolongada de aplicacion semestral. Comunicacion preliminar.]
  49. The use of cases and other teaching tools to improve family planning program management.
  50. Use of effective birth control in LDCs.
  51. The use of estrogen as a postcoital contraceptive in North Carolina: trick or treatment.
  52. The use of estrogens as postcoital contraceptive agents.
  53. The use of market research firms in family planning programs.
  54. Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination.
  55. Use of postabortion contraceptives: evaluation of a program of prevention of repeated abortion. [Uso de anticonceptivos post-aborto. Evaluacion de un programa de prevencion del aborto reiterado.]
  56. Use of the oral contraceptive Femigen-Polfa by epileptic women. [W sprawie stosowania doustnego preparatu antykoncepcyjnego Femigen-Polfa u kobiet chorych na padaczke.]
  57. User reliability check needed in evaluation of contraceptives.
  58. Using commercial resources in family planning communication programs: the international experience.
  59. Uterine bleeding in rhesus monkeys after insertion of polyethylene and copper containing polyethylene intrauterine contraceptive devices.
  60. Utilization of para-medical personnel in family planning program.
  61. Utilization of research in a family planning action program -- a case study of Bangladesh.
  62. Utilization of traditional birth attendants for recruiting family planning acceptors and resupplying of oral contraceptives: a summary of Malaysia's experience.
  63. The value of colposcopy in the detection of early cervical neoplasias in a family planning center. (Abstract only)
  64. Vascular changes of the fundus caused by oral contraceptives. [Gefaessveraenderungen im Augenhintergrund, verursacht durch Kontrazeptiva.]
  65. Vascular lesions and thromboembolic vascular occlusions following oral contraceptives. [Gefaesswandschaedigung und thromboembolische Gefaessverschluesse nach Einnahme von Ovulationshemmern.]
  66. Vasectomy as a contraceptive choice in Latin America.
  67. Vasectomy for contraception: physiological perspectives.
  68. Vasectomy found becoming popular in U.S. as a birth control means.
  69. A vasectomy service in a free-standing family planning center: one year's experience.
  70. Vasectomy: how it affects a man's physical and mental health, sexual life, and marriage: 1. Vasectomy as a preferred method of birth control: Excerpts from an investigation of 29 cases.
  71. Venezuelan family planning: winning government support.
  72. Vietnam (South). (Family planning)
  73. Vitamin-B6 deficiency during treatment with oral contraceptives. [Vitamin-B6-Verarmung bei Einnahme oraler Contraceptiva.]
  74. The in vitro binding of estradiol to human platelets before and during oral contraceptive treatment. (Abstract only)
  75. Voluntary sterilisation as a component of family planning.
  76. Voluntary sterilization as a component of family planning programme.
  77. Voluntary sterilization: the new birth control.
  78. Warning on contraceptive packaging.
  79. (Warning on contraceptive packaging.)
  80. What do we know about family planning communication in Indonesia?
  81. What is the population/family planning field doing about utilizing research?
  82. When to begin contraception after pregnancy.
  83. Who needs family planning?
  84. WHO task forces in contraception.
  85. Who uses family planning?
  86. Why aren't we communicating as we ought to? Some observations on communication patterns in family planning.
  87. Why do unmarried women fail to use contraception?
  88. Women doctors and family planning. (Letter to the editor)
  89. Women doctors and family planning. (Letter to the editor)
  90. Women's rehabilitation towards emancipation: practice, prospects and problems for family planning.
  91. Women's rights, family planning and family size: an international perspective.
  92. Women, participation and family planning. [Mujer, participacion y planificacion familiar.]
  93. Working paper. (Family planning programs)
  94. Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids.
  95. Randomised double-blind trial of four oral progestagen-only contraceptives.
  96. The effect of intrauterine contraceptive device (IUD) on pregnancy in the rabbit.
  97. Effects of progestogen oral contraception with norethisterone on blood clotting and platelets.
  98. Experience with depo-medroxyprogesterone acetate as a contraceptive agent.
  99. Family planning. [La pianificazione della famiglia.]
  100. Further studies on long-term contraception by subcutaneous Silastic capsules containing megestrol acetate.
  101. Implications of selective feedback in aspects of family planning research for policy-makers in India.
  102. Intrauterine contraception with the copper-T device: effect on trace elements in the endometrium, cervical mucus and plasma.
  103. Malignant hypertension, uremia and hemolytic anemia in a patient on oral contraceptives.
  104. A metabolic balance study of the effects of an oral steroid contraceptive on weight and body composition.
  105. A survey of contraceptive markets in four African countries.
  106. Raised serum-lipids and oral contraceptives. (Letter to the editor)
  107. Rare dermatological indications for treatment with contraceptive hormones. [Seltenere dermatologische Indikationen fuer eine Behandlung mit Kontrazeptiven Hormonen.]
  108. Rate limiting factors in the development of new contraceptive methods.
  109. Rates of practicing contraception.
  110. Recent advances in contraceptive technology.
  111. Recent advances in family planning.
  112. Recent developments in hormonal contraception. [Neuere Verfahren der hormonalen Contraception.]
  113. Record of contraceptive procurement and supply, 1962-1969.
  114. Reduced red cell filterability with oral contraceptive agents.
  115. The Regional Seminar on Family Planning and Demographic Aspects, Southern Region.
  116. Relation between the duration of use of hormonal oral contraceptives and the time required to conceive. [Relacao do tempo de uso de anticoncepcionais hormonais orais e tempo para conceber.]
  117. The relation of growth hormone to altered carbohydrate metabolism in women taking oral contraceptives.
  118. The relationship of family planning to savings and consumption in Taiwan.
  119. Relationship of oral contraceptives to cervical carcinogenesis.
  120. Relationship to health personnel and other family planning workers.
  121. Reliability of the Czechoslovak contraceptive devices. [Spolahlivost ceskoslovenskych antikoncepcnych prostriedkov.]
  122. Religious attitudes towards family planning.
  123. Removal of an intra-abdominal intrauterine contraceptive device through a peritoneoscope with the use of intraoperative fluoroscopy to aid localization. (Letter to the editor)
  124. Removal of intra-abdominal intrauterine contraceptive devices through a peritoneoscope with the use of intraoperative fluoroscopy to aid localization.
  125. Removal of intrauterine contraceptive devices after uterine perforation.
  126. Reply to Dr. Eichner. (Oral contraceptives) (Letter to the editor)
  127. A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives.
  128. Report of a country survey on the Role of Home Economics in Family Planning, Liberia, April 3-24, 1972.
  129. Report of a country survey: the role of home economics in family planning (Philippines)
  130. Report of a village family planning clinic.
  131. Report of the Expert Group on the role of voluntary organizations in national family planning programmes, Bangkok, August 7-12, 1972. (Second Asian Population Conference, Tokyo, November 1-13, 19729) 1972. 26 p.
  132. Report of the Task Force on Psychology, Family Planning, and Population Policy.
  133. Report of the working group on training of personnel in family planning programmes.
  134. Report on the inter-regional conference on the integration of maternal and child health services including family planning into basic health services.
  135. A report to the Commonwealth Fund on Planned Parenthood of New York City's Specialized Service Program for Young People, 18 and Younger. November 1969-December 1971.
  136. Republic of Korea (Family planning)
  137. The Republic of Korea's efforts, achievements and problems in family planning.
  138. Republic of Vietnam (Family planning)
  139. Nicaragua. (Family planning)
  140. Nigeria (Family planning)
  141. NIPP (National Institute of Family Planning) to undertake WHO-aided project on male pill.
  142. Non-economic benefits of family planning.
  143. Non-hypophyseal and gonadal loci of contraception.
  144. Nonmonetary commodity incentives in family planning programs: a preliminary trial.
  145. The nurse clinician in family planning.
  146. Nursing and auxiliary personnel in family planning.
  147. Nursing, sterility and contraception: opinions before the 19th century. [Allaitement, sterilite et contraception: les opinions jusqu'au XIXe siecle.]
  148. Nutrition, family planning and fertility.
  149. Observations on family planning and abortion in Sweden: notes on a March 1972 visit to Stockholm.
  150. Obstacles to progress in family planning.
  151. Obstetrical and medical indications for family planning. (Africa)
  152. Occurrence of porphyria cutanea tarda following contraceptive treatment. [Das Auftreten von Porphyria cutanea tarda nach kontrazeptiver Therapie.]
  153. On family planning.
  154. On the Government and birth control: statement of the Administrative Board of the National Catholic Welfare Conference, November 14, 1966.
  155. An on-the-spot report of international family planning attitudes in October 1971.
  156. Open discussion on management of women seeking family planning help.
  157. Operative removal of intraperitoneal intrauterine contraceptive devices - a reappraisal.
  158. Oral contraception and diabetes mellitus.
  159. Oral contraception and liver fluke disease.
  160. Oral contraception. [Die orale Kontrazeption.]
  161. Oral contraception. [Srodki antykoncepcyjne doustne.]
  162. Oral contraceptive agents and vitamins.
  163. Oral contraceptive and folate metabolism.
  164. The oral contraceptive and variegate porphyria.
  165. Oral contraceptive distribution in five selected countries.
  166. Oral contraceptive hypertension.
  167. Oral contraceptive metabolism and drug interaction.
  168. Oral contraceptive steroids and carbohydrate metabolism.
  169. Oral contraceptive steroids, norethynodrel and mestranol: effects of tissue uptake and utilization of glucose-U-carbon-14. (Abstract only)
  170. Oral contraceptive therapy and breast diseases, a morphological study. [Brustdrusenveranderungen nach Langzeitbehandlung mit sogenannten Ovulationshemmern.]
  171. Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection.
  172. Oral contraceptives after cervical cancer.
  173. 1243 requests for abortion: the role of oral contraceptive failure. [1243 demandes d'interruption de grossesse: role de l'echec de la contraception orale.]
  174. 28% have had sexual relations: half of these used no contraception.
  175. 3 cases of cataract occurring in women taking the same oral contraceptive. Is this coincidence? [Trois observations de cataracte survenue chez des femmes prenant le meme contraceptif par voie orale. S'agit-il d'une coincidence?]
  176. A 3-year longitudinal evaluation of the costs of a family planning program.
  177. A.I.D. projects in population and family planning.
  178. Abortion and contraception in Sweden 1870-1970.
  179. Abortion and contraception.
  180. Abortion and contraception: a study of patients' attitudes.
  181. Abortion and family planning.
  182. Abortion and family planning. [Abtreibung und Familienplanung.]
  183. Abortion in perspective of family planning. (Letter to the Editor)
  184. Absorption of oral contraceptives.
  185. Acceptability and use-effectiveness of an oral contraceptive in a rural area.
  186. Acceptability of an injectable contraceptive in a rural population of Thailand.
  187. The acceptability of contraception to Australian aboriginal women.
  188. The acceptability of contraceptive sterilization among U.S. couples: 1970.
  189. Action of a contraceptive steroid on lineage. [Action d'un steroide anticonceptionnel sur la descendance.]
  190. Additional births averted when abortion is added to contraception.
  191. Administration and organisation of and family planning services.
  192. Administration and organisation of the family planning service in India.
  193. Administration and organisation of the family planning services in India.
  194. Adoption of family planning as a way of life in developing countries.
  195. Advising patients on the risks of oral contraception.
  196. An aggregate analysis of population policy formation: the case of family planning in Latin America, Africa, and Asia.
  197. Alterations in the nicotinic acid route of tryptophan metabolism in women taking oral contraceptives. [Sulle alterazioni del metabolismo del triptofano via acido nicotinico nelle donne che assumono contraccettivi.]
  198. Amendment Slip No. 1, published June 9, 1972. to B.S. 4028: 1966, diaphragms for contraceptive use. Revised text.
  199. Amenorrhea following oral contraceptives.
  200. Amenorrhea following use of oral contraceptives.
  201. The amenorrhea-galactorrhea syndrome following oral contraceptives.
  202. Amenorrhoea following oral contraception.
  203. And for fear of bearing child, they became blind or dumb... or, in parable form:" O.N.O. (oto-neuro-ophthalmological) accidents due to oral contraceptives." ["Et la crainte d'infanter les rendit aveugle ou muette..." ou sous forme de parabole: "Accidents O.N.O. des contraceptifs oraux."]
  204. Annual report for 1971. (Family planning in Ireland)

     

  205. Annual report of Family Planning Department. (India)
  206. Anthropology and population research: application in family planning programs.
  207. The antigon-F: an improved intrauterine contraceptive device.
  208. Antithrombin 3 and the oestrogen content of combined oestro-progestagen contraceptives. (Letter to the editor)
  209. Antithrombin III concentration in women using low-dosage progestogen for contraception.
  210. Appendices. (Family planning)
  211. An application of a Monte Carlo model to estimate births averted due to various family planning methods.
  212. An application of path analysis to study variation in acceptance of the family planning programme in India, 1966-71.
  213. An application of probit analysis to a family planning problem: are cash incentives effective in a sterilization programme.
  214. Applying models to the family planning programs of developing countries.
  215. Aspirin as a contraceptive: the prostaglandins strike again.
  216. Assessing the needs of family planning information, education and communications programs. Discussion paper.
  217. Assessment and projection of cost of family planning: a review of methodology.
  218. Assessment of knowledge and attitudes to family planning.
  219. The Athoor experience: implications for a statewide family planning program.
  220. Attitudes and practices of graduate school teachers towards family planning.
  221. Attitudes of 30 American Indian women toward birth control.
  222. Attitudes of lower class males toward taking a male birth control pill.
  223. Attitudes of Mexican women vis-a-vis the people's position on contraception. [Attitudes de femmes Mexicaines face a laposition du pape sur la contraception. On Contraception.]
  224. Attitudes to different types of contraceptive.
  225. Attitudes to family planning.
  226. Audiovisual material and methods in the service of family planning communication.
  227. Australia (Family planning)
  228. Australian fertility and family planning survey, 1971.
  229. Auxiliary midwife prescription of oral contraceptives.
  230. Bangladesh bazaars may sell contraceptives.
  231. Behavioral factors in non-coital methods of contraception: a review.
  232. Belief systems and family planning in peasant societies.
  233. Benefit cost approaches to family planning programs.
  234. Benefits of family planning emphasized.
  235. Bhivpuri family planning project--a well participated rural "pill" programme.
  236. Bibliography of birth control in China.
  237. Biological action of copper: development of a new type of intra-uterine contraception - Cu-7.
  238. Birth control among the unmarried in Massachusetts: the Supreme Court speaks in varied tongues.
  239. Birth control and the ideals of marital sexuality.
  240. Birth control and the private physician.
  241. Birth control as domination.
  242. Birth control by astrology?
  243. Birth control campaign.
  244. Birth control in India. [Controllo delle nascite in India.]
  245. Birth control usage among abortion patients.
  246. Birth control, family planning and problems of abortion in the member states of the Council of Europe) [Controle des naissances, planning familial et problemes de l'avortement dans les etats membres du Conseil de l'Europe.]
  247. Birth control, sex-ratio, and anencephaly.
  248. Birth control. [Il controllo delle nascite.]
  249. Birth control. [Le controle des naissances.]
  250. A birth-control plan.
  251. Birth-control.
  252. Births averted by a multi-method family planning program.
  253. Black attitudes regarding contraception, abortion, and sterilization.
  254. Blood lipid levels during hormonal contraception. [Hladiny krevnich lipidu pri hormonalni antikoncepci.]
  255. Bolivia. (Family planning)
  256. Botswana (Family planning)
  257. A brief report on the training course on "fertility and family planning evaluation" organized in Iran.
  258. A brief review of the Swedish R.F.S.U.'s (Association for Sex Education) marketing campaign and its implications for I.P.P.F. family planning associations.
  259. A brief study of Islam's view on planned parenthood.
  260. A brief survey of the content of information materials in family planning.
  261. A Brisbane family planning survey.
  262. A Brisbane family planning survey. (Letter to the editor)
  263. Burma (Family planning)
  264. Burundi (Family planning)
  265. The Calgary Family Planning Clinic - aims and reality.
  266. Call for free contraceptives.
  267. Cambodia (Family planning)
  268. Can a woman who's unhappy with one contraceptive find happiness with another? (Advertisement)
  269. Can mass media advertising increase contraceptive use?
  270. Canadian Nurses' Association position (statement of beliefs) on family planning and related health care.
  271. Cancer-inducing effects of Nitroso-methylurea after administration of hormonal contraceptives. [Die krebserzeugende Wirkung des N-Nitroso-methylharnstoffes nach Verabreichung hormonaler Kontrazeptiva.]
  272. Carcinogenicity tests of oral contraceptives.
  273. The cardiovascular effects of oral contraceptives.
  274. A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix.
  275. Case histories in family planning, 1972.
  276. A case of axillary-subclavian phlebitis after taking oral contraceptives. [Un cas de phlebite axillo-sous-claviere apres prise de contraceptiforal.]
  277. A case of jaundice due to oral contraceptives. [Un caso di ittero da contraccettivi orali.]
  278. Catholic church and birth control in Latin America: sociological aspects of change and dependency among Catholics.
  279. Catholics and contraception.
  280. Central African Republic (Family planning)
  281. Cerebrovascular lesions related to the use of oral contraceptives. [Zerebro-vaskulaere Insulte in Abhaengigkeit von der Ovulationshemmereinnahme.]
  282. Cervical lesions and their treatment in women using intrauterine contraceptive devices. [Cervikalne lezije njihovo lecenje kod zena koje upotrebljavaja intrauterina kontraceptivna sredstva.]
  283. Changes found in the hemostasis of women using oral contraceptives. [Promeni v khemostazata pri zhenite, upotrebyavascha khormonalni kontratseptivni sredstva.]
  284. Changes in breast size during prolonged use of contraceptive injections.
  285. Changes in the coagulation and fibrinolytic systems in females using intrauterine contraceptive device.
  286. Changing attitudes toward abortion, sterilization, and contraception.
  287. Characteristics of clinic personnel may influence family planning acceptance.
  288. Characteristics of family planning acceptors at Philippine program clinics January to December 1971.
  289. The characteristics of fertility and birth control behaviour in Korea.
  290. Characteristics of persons who have adopted different methods of family planning in southern region.
  291. Characteristics of women using different methods of contraception: some preliminary findings from a prospective study.
  292. Characterization of metabolites of steroid contraceptives by gas chromatography and mass spectrometry.
  293. Child health and family planning.
  294. Child health and family planning. (Letter to the editor)
  295. Childbearing and family planning.
  296. China (Family planning)
  297. China's birth control program is the best in the world, IPPF observer reports.
  298. Chinese expand medical, family planning services.
  299. Chloasma uterinum associated with oral contraceptives. [Chloasma uterinum durch Kontrazeptiva.]
  300. Choice of contraception in various periods of a woman's life. [Kotazke planovania rodicovstva u zien s tuberkulozou.]
  301. Choice of contraception in various periods of a woman's life. [Volba antikoncepcni metody v ruznem obdobi zivota zeny.]
  302. Chromosomal satellite association in women using oral contraceptives and their progeny.
  303. Class study: contraception: Part 2.
  304. A clear road for contraceptives. [Via libera per gli anticoncezionali.]
  305. Clinical and laboratory findings in a trial of norgestrel, a low-dose progestogen-only contraceptive.
  306. Clinical and morphological aspects of cerebrovascular accidents under oral contraception. [Klinische und morphologische Aspekte cerebrovascularer Ereignisse bei oralen Antikonzeptiva.]
  307. Clinical and morphological aspects of cerebrovascular manifestations with oral contraceptives (Abstract only) [Klinische und morphologische Aspekte cerebrovaskulaerer Ereignisse bei oralen Antikonzeptiva.]
  308. Clinical and pathological study of the effects of contraceptive treatment with mestranol-lynestrol by a sequential method. [Estudio clinico-patologico de los efectos de la terapia contraceptiva con mestranol-linestrol en una modalidad del tipo sequencial.]
  309. Clinical aspects of oral contraceptive-induced pigmentation changes. [Klinik der Pigmentveranderungen durch orale Kontrazeptiva.]
  310. Clinical evaluation of an IUD with 200 sq. mm of copper: a new approach in human contraception.
  311. Clinical experiences concerning the intramuscular contraceptive oxogestone.
  312. Clinical experiences with a new peroral contraceptive. [Kliniska erfarenheter av ett nytt peroralt antikonceptionsmedel.]
  313. Clinical field test of a new contraceptive vaginal foam tablet.
  314. Clinical problems of modern contraception. [Problemi clinici della moderna contraccezione.]
  315. Clinical studies of varying doses of norethindrone oxime acetate as a contraceptive agent.
  316. Clinical studies on the continuous administration of ethynoliol di acetate sc-11800 for contraception and dysmenorrhea.
  317. Clinical study of a continuous daily micro-dose progestogen contraceptive--d-norgestrel.
  318. Coagulation assays in detecting thrombosis-prone patients on oral contraceptives.
  319. Combined effect of psychological factors upon birth control and their relative importance.
  320. A commercial approach to family planning.
  321. Commercial distribution of contraceptives in Colombia, Iran, and the Philippines.
  322. Commercial distribution of contraceptives.
  323. The commercial distribution of contraceptives: a non-medical supplement to the family planning effort.
  324. Communicating family planning: a practical handbook based on the contributions from the Workshop on Family Planning Education in Africa, Accra, Ghana, November 1970.
  325. Communication and change: some perspectives for a total communications program for family planning in the Philippines.
  326. Communication in family planning.
  327. Communication in family planning.
  328. Communication networks, locus of control, and family planning among migrants to the periphery of Mexico City.
  329. Communication research and family planning.
  330. Communications-education in family planning strategy for Muslim society: the Indonesian case.
  331. Community health services and family planning.
  332. Comparative study of intrauterine contraceptive devices.
  333. Complications of contraception with intrauterine devices. [Zur Frage der Komplikationen bei Antikonzeption mit intrauterinen Pessar en.]
  334. Complications of contraception. [Les accidents de la contraception.]
  335. Concentration of Antithrombin III during combined and progestogen-only oral contraceptive treatment.
  336. Concept of Islam on family planning.
  337. Conception and contraception.
  338. A conceptual framework for viewing responses to family planning programs.
  339. Conclusion. (Law, politics, and birth control)
  340. Condom and contraception. (Letter to the editor)
  341. Conference on intrauterine contraception, Toulouse, November 22, 1970. [Colloque sur la contraception endo-uterine. Toulouse, 22 novembre 1970.]
  342. Consensus between husbands and wives in the area of family planning: a comparative analysis of couples who have and couples who have not performed an induced abortion.
  343. Consumer participation in a family planning program.
  344. Continuation rates, complaints and reasons for discontinuance relating to contraceptive pills: an Indian experience.
  345. Continuous administration of progestogens and contraception with progesterone releasing devices.
  346. Contraception (part 1) (an edited version of a class project presented by the November 1971-May 1972 midwifery class at St. Helens Hospital, Welling, New Zealand)
  347. Contraception and behaviour.
  348. Contraception and community health.
  349. Contraception and infertility.
  350. Contraception and lactation.
  351. Contraception and microangiopathy--Preliminary note. [Contraception et micro-angiopathie--note preliminaire.]
  352. Contraception and prevention of uterine cervix cancer. [Antikoncepce a prevence rakoviny delozniho hrdla.]
  353. Contraception and sex education.
  354. Contraception and the reproductive function. [Kontratseptsiya i reproduktivnaya funktsiya.]
  355. Contraception by "vicarious" voluntary male sterilization. [Zur Empfangnisverhutung durch "vikariierende" freiwillige Sterilisierung des Mannes.]
  356. Contraception by an injectable long-acting oestrogen-progestogen agent.
  357. Contraception for adolescent girls. [Zur Antikonzeption bei weiblichen Jugendlichen.]
  358. Contraception for teenagers.
  359. Contraception for the needy.
  360. Contraception guidance at Christies Street Health Center. One year's material. [Prevensjonsveiledning ved Christies-gate helsestasjon. Et ett-arsmateriale.]
  361. Contraception in adolescents.
  362. Contraception in Costa Rica: the role of the private sector 1959-1969.
  363. Contraception or abortion?
  364. Contraception or abortion? (a) Usage of contraception and abortion.
  365. Contraception using Dalkon Shields.
  366. Contraception using Dalkon shields. (Letter to the editor)
  367. Contraception with 3-months injections. [Kontrazeption mit der 3-Monats-Spritze.]
  368. Contraception with a daily low-dose progestogen: quingestanol acetate.
  369. Contraception with an intra-uterine bow inserted immediately post partum: a progress report.
  370. Contraception with intrauterine devices, 1959-1966.
  371. Contraception with the endouterine copper T. A preliminary report.
  372. Contraception with the lynestrenol "mini-pill."
  373. Contraception, abortion, prostaglandins and sterilization. [Contraception, avortement, prostaglandines et sterilisation.]
  374. Contraception.
  375. Contraception.
  376. Contraception.
  377. Contraception.
  378. Contraception: by choice or by chance.
  379. Contraception: the ovulation method. (Letter to the editor)
  380. Contraception: yes, but. [Contraception: oui, mais.]
  381. Contraceptive action of impeding estrogens. VIII. The post-coital activity of estriol ethers in the rat.
  382. Contraceptive antecedents to early and late therapeutic abortions.
  383. Contraceptive conundrum I.
  384. Contraceptive discontinuation among patients using oral and intrauterine methods.
  385. Contraceptive education and the Colombian druggists.
  386. Contraceptive education and the Colombian druggists. (Abstract only)
  387. Contraceptive effect and tolerance of monthly oral doses of Quinestrol.
  388. Contraceptive effect of intrauterine devices in rats following intersection of the septum dividing the uterine horns. [Protivozachatochnyi effekt vnutrimatochnovo kontraktseptiva u krys posle peresecheniya peregorodki, razdelyayuschei roga matki.]
  389. Contraceptive effect of iron: evaluation of the vaginal iron reabsorption in rats.
  390. Contraceptive effect of iron: local compatibility of vaginally applied iron in rats and nice.
  391. Contraceptive effects of an intra-uterine device in the mouse. (Abstract only)
  392. Contraceptive methods.

     

  393. Contraceptive pills.
  394. Contraceptive practice among New York abortion patients.
  395. Contraceptive practice: More research needed in rhythm methods.
  396. Contraceptive practices of unmarried university students. [Pratiques contraceptives d'etudiants universitaires celibataires.]
  397. A contraceptive program for teenagers: the San Francisco experience.
  398. Contraceptive provision in the immediate postpartum period.
  399. Contraceptive research: a male chauvinist plot?
  400. Contraceptive ring inserted for a long period.
  401. Contraceptive services in Latin America.
  402. Contraceptive sterilization in the U.S.: 1965 and 1970.
  403. Contraceptive sterilization.
  404. Contraceptive steroids and serum lipids. [Esteroides anticonceptivos y lipidos sericos.]
  405. Contraceptive technology 1972.
  406. Contraceptive treatment with chlormadinone and its effect on the endometrium. A histological investigation.
  407. Contraceptive use - efficacy study utilizing Depo-Provera administered as an injection once every six months.
  408. Contraceptive use in the Singapore national programme July 1972 to June 1975.
  409. Contraceptives and hair growth, an experiment using pregnant laboratory animals as models. [Kontrazeptiva und Haarwachstum unter tierexperimentellen Aspekten am Modell der Traechtigkeit.]
  410. Contraceptives, hypertension and renin. (Letter to the editor)
  411. The control and surveillance of systemic contraceptives in Australia.
  412. Controlled, intrauterine drug administration: a novel approach to safe and effective contraception.
  413. The copper contraceptive mystery.
  414. Copper in intrauterine contraceptive devices.
  415. Correlates of inter-district variation in the progress of family planning in Kerala.
  416. Cost effectiveness; $66 a patient annual family planning cost.
  417. A cost-effectiveness study of clinical methods of birth control: with special reference to Puerto Rico.
  418. Costa Rica: measuring the demographic impact of family planning programs.
  419. The costs and benefits of family planning.
  420. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
  421. Cuba. (Family planning)
  422. Culdoscopy as an aid to family planning.
  423. Cultural changes in relation to a sustained country-wide family planning program (Philippines)
  424. Cultural changes in relation to a sustained country-wide family planning programme.
  425. Cultural factors affecting family planning.
  426. Current and future place of oral contraception. [Place actuelle et avenir de la contraception orale.]
  427. Current questions on the use of hormonal contraceptive preparations. [Questions actuelles pour l'utilisation des preparations hormonales contraceptives.]
  428. Current status of contraceptives in population control.
  429. The cutaneous effects of the contraceptive pill. (Abstract only)
  430. Cytologic observations of cervicovaginal smears during hormonal contraception. [Observations cytologiques de frottis cervico-vaginaux sous contraception hormonale.]
  431. Cytological aspects of cervico-vaginal smears from patients treated with oral contraceptives. [Aspect cytologique des frottis cervico-vaginaux provenant des patientes soumises a un traitement anticonceptionnel par voie orale.]
  432. Cytological observations of cervico-vaginal smears on hormone contraception.
  433. The Dacca family planning experiment.
  434. Daily chlormadinone acetate as an oral contraceptive.
  435. Daily microdose norgestrel as a contraceptive: a preliminary report.
  436. The Danfa/Ghana comprehensive rural health and family planning project - a community approach.
  437. The Danfa/Ghana comprehensive rural health and family planning project - preliminary report.
  438. Decision factors in family planning communications for the Philippines.
  439. A decision making system for a family planning program: a case study of Taiwan.
  440. Decision-making patterns of family planning among husbands and wives: some theoretical issues.
  441. Decreased serum B12 levels with oral contraceptive use.
  442. Deep thrombophlebitis of the leg in a Chinese woman on oral contraceptive pill.
  443. Deep venous thrombosis of the upper extremity possibly related to oral contraceptives: case reports.
  444. Deficiencies in the family planning programme and measures to effect improvement in the concerned area.
  445. Demographic and social aspects of contraceptive sterilization in the United States 1965-1970.
  446. Demographic impact of national family planning programme in India.
  447. Depo-medroxy progesterone acetate as an immediate post-partum injectable contraceptive.
  448. Depo-medroxyprogesterone acetate as a contraceptive agent: its effect on weight and blood pressure.
  449. Depo-Provera contraception: international experience in over 20,000 cases.
  450. Depo-Provera contraception: international experience in over 20,000 cases.
  451. Depot estrogen as a monthly contraceptive in nulliparous women with mild uterine hypoplasia.
  452. Depressed lymphocyte response to P.H.A. in women taking oral contraceptives. (Letter to the editor)
  453. Depression, libido, sexual appetite and contraception. [Depression, libido, appetit sexuel et anticonception.]
  454. Descriptive analysis of information campaign materials for family planning in the Philippines: a pilot study of the print media.
  455. Desirable and undesirable cutaneous effects of oral contraceptives.
  456. Desired family size and efficacy of current family planning programmes.
  457. Development administration in a North Indian state: the family planning program in Uttar Pradesh.
  458. The development of model training programmes for family planning communicators.
  459. Developmental communication studies in the Philippines: implications for research, development of materials and training in family planning communication.
  460. DHEW Five-year plan: serve 6.6 million, spur research for new contraceptives by 1975.
  461. The diffusion of contraceptive innovation among the urban poor in Jamaica.
  462. Do contraceptive steroids have adverse effects on progeny? [Les steroides anticonceptionnels ont-ils des effets nocifs pour la descendance?]
  463. Do hormonal contraceptives affect tumor growth? [Haben hormonale Contraceptiva einen Einfluss auf das Geschwulwachstum?]
  464. Doctors and Dunkuns, puppets and pills: a look at Indonesia's family planning program.
  465. Domiciliary family planning service.
  466. Domiciliary family planning service. (Letter to editor)
  467. Domiciliary midwives and birth control advice 1970/71 - Part 1.
  468. Domiciliary midwives and birth control advice 1970/71 - Part 2.
  469. Draft of the proceedings of the expert group meeting on contraceptive production and distribution and the plant study tour for selected participants.
  470. The dukun's performance as a family planning worker.
  471. The dynamics of change: publicly supported birth control.
  472. ECAFE meeting explores role of voluntary organisations in family planning.
  473. Ecology of contraception.
  474. Economic incentives: a strategy for family planning programs.
  475. Educating adults in family planning.
  476. Education and training for family planning in health services.
  477. Education and training of health statisticians in family planning.
  478. Educational program in family planning in medical colleges and hospitals.
  479. EEG abnormalities found in healthy women under contraceptive medication: short term studies.
  480. Effect of a progestogen oral contraceptive compound on carbohydrate metabolism.
  481. Effect of an intrauterine contraceptive device in vitro uptake of estradiol-17beta-6, 7-tritiated by the endometrium: a preliminary study.
  482. Effect of an oral contraceptive on NaCl appetite and preference threshold of rats. (Abstract only)
  483. Effect of contraceptive on the periodontal tissue of rats.
  484. Effect of contraceptive suture on biochemical composition of uterine fluid of protein deficient rats.
  485. Effect of gestranol used as a contraceptive on the level of some aminotransferases. [Wplyw gestranolu stosowanego w celach antykoncepcyjnych na aktywnosc niektorych aminotransferaz.]
  486. The effect of hormonal contraceptives on tumor growth.
  487. The effect of intrauterine contraception on the condition of fertilized ova of the rat. [Vliyanie vnutrimatochnovo kontratseptiva na sostoyanie oplodotvorennykh yaitsekletok krysy.]
  488. Effect of intrauterine contraception on the ultrastructure of the uterine mucosa. [Wirkung der intrauterinen Antikonzeption auf die Ultrastruktur der Uterusschleimhaut.]
  489. The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure.
  490. Effect of oral contraception on blood pressure.
  491. Effect of oral contraception on carbohydrate metabolism. [Effet de la contraception orale sur le metabolisme des glucides.]
  492. The effect of oral contraceptive agents on platelet electrophoretic mobility.
  493. Effect of oral contraceptive medication and pryridoxine supplementation on serum and erythrocyte aminotransferase activity. (Abstract only)
  494. Effect of oral contraceptive on folate metabolism.
  495. Effect of oral contraceptives and sulfonylurea on carbohydrate metabolism.
  496. Effect of oral contraceptives on carbohydrate metabolism. Hormonal contraception and diabetes mellitus. [Influence des contraceptifs oraux sur le metabolisme glucidique. Contraception hormonale et diabete sucre.]
  497. The effect of oral contraceptives on fibrin-clot stabilization.
  498. The effect of oral contraceptives on microcirculation.
  499. Effect of oral contraceptives on the liver in women with recurrent cholestasis (hepatosis) during previous pregnancies.
  500. Effect of peroral contraceptive preparation Femigen upon the erythrocyte and resin up-take of iodine-131-triiodothyronine. [Wplyw preparatu Femigen stosowanego dla celow antykoncepcyjnych na wartosci wychwytu erytrocytowego i zywicowego 131J-trojjodotyroniny.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.